MedTrace Logo

Exploratory Study of Natural Killer Cells in Human Skin

NCT00824889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2014-08-29

No results posted yet for this study

Summary

Natural Killer (NK) cells play a unique role during innate immune responses as they are able to recognize and eliminate, without specific sensitization, tumors, microbe-infected cells as well as allogeneic cells.In a first time, we will characterize the tissue distribution, the phenotype and the effector functions of NK cells present in the human healthy skin.

Conditions

Interventions

OTHER

Biopsy and sample of blood

Biopsy and sample of blood

OTHER

Biopsy and sample of blood

Biopsy and sample of blood

OTHER

Biopsy and sample of blood

Biopsy and sample of blood

OTHER

Biopsy and sample of blood

Biopsy and sample of blood

OTHER

Biopsy and sample of blood

Biopsy and sample of blood

OTHER

Biopsy and sample of blood

Biopsy and sample of blood

OTHER

Biopsy and sample of blood

Biopsy and sample of blood

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • Caroline Gaudy-Marqueste, MD · Assistance Publique des Hopitaux de Marseille

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00824889 on ClinicalTrials.gov